U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX4096894: GSM3145667: IBC3_TRPS1_2 [ChIP-seq]; Homo sapiens; ChIP-Seq
1 ILLUMINA (NextSeq 500) run: 44.7M spots, 3.4G bases, 1.4Gb downloads

Submitted by: NCBI (GEO)
Study: TRPS1 is a lineage-specific transcriptional dependency in breast cancer [Seq]
show Abstracthide Abstract
We performed an unbiased cell viability-based pooled shRNA screen on 59 cell lines to identify novel epigenetic and transcriptional dependencies of multiple cancer types, including leukemia, neuroblastoma, breast, colorectal, prostate, and rhabdoid tumors. Here, we identified Tricho-Rhino-Phalangeal Syndrome Type I protein (TRPS1) as one of the most significant hits specific for breast cancer cell lines. Downregulation of TRPS1 resulted in cell cycle arrest and apoptosis increase in vitro and impaired tumorigenic capacity in vivo. We characterized TRPS1 genomic targets and protein interactome. We identified GATAD2B as an important partner of TRPS1, uncovering novel epigenetic network crucial for breast cancer cell survival. Overall design: Bulk RNA-Seq: Gene expression analysis of 57 cell lines used in the screen and HCC3153 and SUM159 cell lines with TET-inducible shRNA against TRPS1 with the following variables: Two different shRNA labeled sh1 (sh41) and sh2 (sh43), doxycyclin (plus/treatment) and no doxycyclin (minus/control), 3, 4 and 5 days after doxycyclin treatment. All conditions were sequenced without replicates (24 samples). ChIP-Seq: Examination of H3K27me3, GATAD2A, GATAD2B, H3K27ac, and TRPS1 in three different cell lines, in duplicates. HCC3153 cell line included the following variables: Two different shRNA labeled sh1 (sh41) and sh2 (sh43), doxycyclin (plus/treatment) and no doxycyclin (minus/control). Please note that the 'DFCI_EpiCluster_RNA-Seq.reads.gct' processed data file includes 4 re-analyzed samples, which were submitted as a part of series GSE63582 and the data columns correspond to the following samples; SUM149PT - GSM1842497 [SUM149_DMSO_12H_R1] SUM149PT_JQ1R_w_JQ1 - GSM1842493 [SUM149R_DMSO_12H_R1] SUM159PT - GSM1553156 [SUM159_DMSO_3H_1] SUM159PT_JQ1R_w_JQ1 - GSM1553147 [SUM159R_DMSO_3H_2]
Sample: IBC3_TRPS1_2 [ChIP-seq]
SAMN09221693 • SRS3313383 • All experiments • All runs
Organism: Homo sapiens
Library:
Instrument: NextSeq 500
Strategy: ChIP-Seq
Source: GENOMIC
Selection: ChIP
Layout: SINGLE
Construction protocol: For RNA-seq total RNA was extracted using the RNeasy Kit (Qiagen). For ChIP-seq 5-8 × 10^6 cells were fixed by adding 1:20 volume of fixing buffer (11% paraformaldehyde (Electron Microscopy Sciences, cat# 15714), 0.1M NaCl, 1mM EDTA pH 8.0, 50mM HEPES pH 8.0) directly to the tissue culture medium for 10 min at room temperature for histone modification ChIPs or at 37°C for transcription factor ChIPs and subsequently quenched by glycine. Cells were lysed in lysis buffer (50mM HEPES pH 8.0, 140mM NaCl, 1mM EDTA, 10% glycerol, 0.5% NP-40, and 0.25% Triton X-100) for 10 min at 4°C. Nuclei were pelleted and washed in wash buffer (10mM Tris-HCl pH 8.0, 200mM NaCl, 1mM EDTA, 0.5mM EGTA) for 10 min at 4°C and then pelleted and resuspended shearing buffer (10mM Tris-HCl pH 7.4, 1mM EDTA, 0.1% SDS, 1% Triton X-100, 0.1% sodium deoxycholate, 0.25% sarkosyl, 1mM DTT) and sonicated in a Covaris sonicator. Debris was removed by centrifugation (5 min at 10,000g) and 970µl of the lysate was mixed with 30µl of 5M NaCl. Chromatin was pre-cleared for 1 hr at 4°C with 40µl of Dynabeads Protein G (LifeTechnologies, cat# 10003D) washed in 0.5% BSA in PBS. Lysates were then incubated with corresponding primary antibody overnight at 4°C. Complexes were precipitated by incubation with 40µl of washed Dynabeads Protein G for 2 hrs at 4°C, washed with low salt wash buffer (20mM Tris-HCl pH 8.0, 150mM NaCl, 2mM EDTA pH 8.0, 1% Triton X-100, 0.1% SDS), high salt wash buffer (20mM Tris-HCl pH 8.0, 500mM NaCl, 2mM EDTA pH 8.0, 1% Triton X-100, 0.1% SDS), LiCl wash buffer (10mM Tris-HCl pH 8.0, 250mM LiCl, 1mM EDTA pH 8.0, 1% NP40, 1% sodium deoxycholate), and twice with TE pH 8.0. DNA was eluted in elution buffer (100mM NaHCO3, 1% SDS) by incubating overnight at 65°C, followed by 30 min treatment with RNase A at 37°C and 2 hrs treatment with proteinase K at 55°C. DNA was purified with phenol-chloroform extraction and precipitated with isopropanol. For methylation analysis, DNA was isolated using QIAamp DNA Mini kit (QIAGEN, cat# 51304). DNA methylation profiling was carried out on Infinium HumanMethylation450K BeadChip arrays (Illumina, discontinued) at the Harvard Medical School-Partners HealthCare Center for Genetics and Genomics. RNA-seq libraries were prepared using Illumina TruSeq Stranded mRNA sample preparation kits from 500 ng of purified total RNA according to the manufacturer's protocol. The finished dsDNA libraries were quantified by Qubit fluorometer, Agilent TapeStation 2200, and RT-qPCR using the Kapa Biosystems library quantification kit according to manufacturer's protocols. ChIP-seq libraries were prepared using the Rubicon ThruPLEX DNA-seq Kit from purified ChIP DNA or input DNA according to the manufacturer's protocol.
Experiment attributes:
GEO Accession: GSM3145667
Links:
Runs: 1 run, 44.7M spots, 3.4G bases, 1.4Gb
Run# of Spots# of BasesSizePublished
SRR717968744,746,9473.4G1.4Gb2018-10-04

ID:
5582455

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...